Follow us on LinkedIn
In memory of one of eXmoor’s founders, our nominated charity for 2017/8 is the Alzheimer’s Research UK. https://www.justgiving.com/fundraising/runfordjd
Without effective treatments, one in three children born today will die with dementia. Today, there are no dementia survivors but research can change this.
Alzheimer’s Research UK is the world’s leading dementia research charity dedicated to causes, diagnosis, prevention, treatment and cure. Backed by our passionate scientists and supporters, we’re challenging the way people think about dementia, uniting the big thinkers in the field and funding the innovative science that will deliver a cure.
Our mission is to bring about the first life-changing dementia treatment by 2025.
With your support, we’ll focus our energies in four key areas of action to make this mission a reality.
- Understand the diseases that cause dementia.
- Diagnose people earlier and more accurately.
- Reduce risk, backed by the latest evidence.
- Treat dementia effectively.
Through these important strands of work, we’re bringing about breakthroughs that will change lives.
Angela Osborne will speak at the Cell and Gene Therapy Manufacturing Workshop “Next generation manufacturing”. The event will take place at Guy’s Hospital, London, 14-15 March 2018. For more information click here
eXmoor cell therapy consultant Reinout Hesselink gave a presentation on Cost of Goods calculations, participated in a discussion on the relationship with a CMO and chaired the Cell, Gene and Immunotherapy Manufacturing, Process Automation and Cold Chain session at the last international CTM & GT Congress held in The Netherlands in Dec 2017.
Will Milligan (Exmoor bioprocess engineer) has been selected for the BIA MAC Bioproduction Leadership Initiative.
The programme was created to support the development of the next generation of bioprocess leaders, as part of BIA MAC’s objectives of connecting, advising and influencing. The development of managers in the biopharmaceutical and cell and gene therapy industries is an important part of the training landscape to deliver senior leaders of the future. Two key aims of the MAC initiative are:
1) to promote cross-sector learning by offering an overview of the work of other companies across biopharma, vaccines and cell and gene therapy by seeing them in action
2) to develop a network with peers to promote best practice
The 16th amc meeting, held on the 8th March in Manchester focusing on the new EU GMP for ATMPs, was sold out! The 17th Autumn meeting will be held on the 4th October in Cologne kindly hosted by Miltenyi Biotec. Keep a watch on the amc website for further details over the next couple of months.